Pinealon Peptide Protects Rat Offspring from Prenatal Homocysteine Damage

During pregnancy, elevated levels of homocysteine, a common amino acid, can lead to a condition called hyperhomocysteinemia. This condition is known to negatively impact fetal development, particularly affecting the brain and leading to cognitive deficits and increased oxidative stress in offspring. This study aimed to investigate if the peptide Pinealon could mitigate these detrimental effects in a prenatal hyperhomocysteinemia model.

The study found compelling evidence that Pinealon administration to pregnant rats with induced hyperhomocysteinemia significantly protected their offspring. Offspring exposed to prenatal hyperhomocysteinemia but treated with Pinealon showed significantly improved cognitive function. Specifically, their spatial orientation and learning ability were enhanced compared to untreated hyperhomocysteinemia offspring. The most important finding was that Pinealon treatment led to cerebellum neurons becoming more resistant to oxidative stress. This neuroprotective effect was further supported by a decreased accumulation of reactive oxygen species (ROS) and a reduced number of necrotic (dead) cells within the isolated cerebellum neurons of the offspring. These findings confirm Pinealon's ability to counteract the neurotoxic effects of prenatal hyperhomocysteinemia.